Literature DB >> 24825134

Nailfold capillaroscopy in Behçet disease, performed using videodermoscopy.

S Aytekin1, E P Yuksel, F Aydin, N Senturk, M G Ozden, T Canturk, A Y Turanli.   

Abstract

BACKGROUND: Nailfold capillaroscopy is used for the identification of microvascular involvement in many rheumatic and extrarheumatic diseases. AIM: To determine the nailfold capillary changes in patients with Behçet disease (BD) by videodermoscopy, i.e. nailfold videocapillaroscopy (NVC).
METHODS: We used a videodermatoscope (Molemax II, × 30 magnification) to perform nailfold capillaroscopy on 40 patients with BD and 40 healthy controls (HC). All nailfold images were evaluated for capillary density, distribution and morphology, assessing features such as enlargement or tortuosity of the capillaries, microhaemorrhages and avascular areas.
RESULTS: Enlarged capillaries were detected in 14 patients, microhaemorrhages in 6 patients, and avascular area in 3 patients. There was a statistically significant difference between patients with BD and healthy controls for capillary dilatation and microhaemorrhages (P < 0.05). Capillaroscopic changes were not associated with sex or clinical characteristics.
CONCLUSIONS: Using NVC, nailfold capillary changes were apparent in patients with BD, but not in HC. NVC could be a useful technique for evaluating microvascular damage in BD.
© 2014 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2014        PMID: 24825134     DOI: 10.1111/ced.12343

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Evaluation of nailfold videocapillaroscopy in central serous chorioretinopathy.

Authors:  Muhammet Kazim Erol; Ayse Balkarli; Devrim Toslak; Berna Dogan; Dogan Durmaz; Elçin Süren; Salih Altun; Mehmet Bulut; Veli Cobankara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-19       Impact factor: 3.117

2.  Capillaroscopic findings in Turkish Takayasu arteritis patients

Authors:  Ali Akdoğan; Abdulsamet Erden; Esra Fırat Şentürk; Levent Kılıç; Alper Sarı; Berkan Armağan; Ömer Karadağ; Sedat Kiraz
Journal:  Turk J Med Sci       Date:  2019-10-24       Impact factor: 0.973

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.